about
Diffuse Axonal Injury: a Brief Review and Examples of the Use of Neurofunctional Imaging (Tc-99m HMPAO SPECT) in Diagnosis and Follow-up.Neuroimaging in the differential diagnosis of primary progressive aphasia - illustrative case series in the light of new diagnostic criteria.Are compression corsets beneficial for the treatment of breast cancer-related lymphedema? New opportunities in physiotherapy treatment - a preliminary reportRelevance of low-pressure compression corsets in physiotherapeutic treatment of patients after mastectomy and lymphadenectomy.Nuclear imaging of amyloidosis.Advantages of hybrid SPECT-CT imaging in preoperative localization of parathyroid glands in a patient with secondary hyperparathyroidism. A case reportEvaluation of usefulness of scintigraphic imaging in diagnosis of intrathecal drug delivery system malfunction - a preliminary report.Carotid Artery Stenting and Blood-Brain Barrier Permeability in Subjects with Chronic Carotid Artery Stenosis.Brain SPECT and Neuropsychological Examination in Patients with a History of Minor Craniocerebral Trauma Nine Years after Head Injury.Early brain spect in patients after minor craniocerebral trauma.Fluorescent Versus Radioguided Lymph Node Mapping in Bladder Cancer.[Micrometastases in sentinel lymph node in endometrial cancer patients].Comparison of Real-Time Fluorescent Indocyanine Green and (99m)Tc-Nanocolloid Radiotracer Navigation in Sentinel Lymph Node Biopsy of Penile Cancer.Nontoxic Goiter (NTG) and Radioiodine: What Do Patients Think About It? Quality of Life in Patients with NTG Before and After 131-I Therapy.Vascular risk factors do not contribute to motor and cognitive impairment in Parkinson's diseaseEffects of acute hypercapnia on the amplitude of cerebrovascular pulsation in humans registered with a non-invasive methodUnilateral neglect in a patient diagnosed with frontotemporal dementia and parkinsonism linked to chromosome 17Preoperative detection of sentinel lymph nodes in endometrial cancer using SPECT/CT68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
P50
Q30682237-A0BEBA1B-AA74-4A41-9F47-FD98AB2B7344Q34392832-602C5093-5F8B-4624-9FBB-DFBA090DD163Q36787839-0E13CFB8-97B2-4D87-8372-C07DA1CD16DCQ37078538-7C19132B-29A6-45CA-BE1C-8BD71DB28FDBQ38234973-46A5A947-0E4D-4D4B-A983-B90E50AB7E87Q41188712-03501A68-620A-404F-A782-4744417C04EEQ42113271-18E3D896-5EB8-4B13-B75A-285518544283Q42229138-D4C0C64B-2A10-4157-8E3B-9C231DE1A568Q48291487-E9CEACE9-4CF0-484D-B66A-A10B9D78FA64Q48357251-66C12862-91AC-4E96-AB66-FFA932C99070Q50212276-7B44C97B-9D47-4378-9B9A-E9791CD65098Q50212663-7D599662-E698-40F8-9065-A8809A58B3CCQ50250893-A00EB1D7-56FA-4BAE-8071-22363CA9AC49Q55003859-BEC75C11-085A-41E2-8B31-6AD0C302BF99Q64761380-880A7C83-0CF3-4581-8C07-285C1A866C4BQ84850632-222F6B62-4FA1-4BB9-B2A5-9BC900E8B1C6Q85937493-BE8CA9BA-BF41-4200-9DF2-E1DC5997E8F4Q86998982-CEB3D611-FC9B-4A53-87DB-4964B3CFB9C6Q90140874-5755CFB8-90F8-4399-ACCB-360CE35D1041
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
P Lass
@en
P Lass
@nl
type
label
P Lass
@en
P Lass
@nl
prefLabel
P Lass
@en
P Lass
@nl
P31
P496
0000-0001-7144-1370